0001209191-21-067644.txt : 20211202
0001209191-21-067644.hdr.sgml : 20211202
20211202170712
ACCESSION NUMBER: 0001209191-21-067644
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211202
FILED AS OF DATE: 20211202
DATE AS OF CHANGE: 20211202
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: TRENARY C RUSSELL III
CENTRAL INDEX KEY: 0001227307
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37759
FILM NUMBER: 211467633
MAIL ADDRESS:
STREET 1: 1700 E ST ANDREW PLACE
CITY: SANTA ANA
STATE: CA
ZIP: 92705
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Outlook Therapeutics, Inc.
CENTRAL INDEX KEY: 0001649989
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 383982704
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0930
BUSINESS ADDRESS:
STREET 1: 485 ROUTE 1 SOUTH
STREET 2: BUILDING F, SUITE 320
CITY: ISELIN
STATE: NJ
ZIP: 08830
BUSINESS PHONE: 6096193990
MAIL ADDRESS:
STREET 1: 485 ROUTE 1 SOUTH
STREET 2: BUILDING F, SUITE 320
CITY: ISELIN
STATE: NJ
ZIP: 08830
FORMER COMPANY:
FORMER CONFORMED NAME: Oncobiologics, Inc.
DATE OF NAME CHANGE: 20150804
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-12-02
0
0001649989
Outlook Therapeutics, Inc.
OTLK
0001227307
TRENARY C RUSSELL III
485 ROUTE 1 SOUTH, BUILDING F
SUITE 320
ISELIN
NJ
08830
1
1
0
0
CEO and President
Common Stock
2021-12-02
4
P
0
10000
1.40
A
10000
D
/s/ Lawrence Kenyon, Attorney-in-Fact
2021-12-02